Fertility drugs don’t raise breast cancer risk

	Tweet

Drugs used to treat female infertility do not appear to be associated with an increased risk of breast cancer, according to a new report.

Based on these findings and others, “infertile women should not worry about breast cancer,” Dr. Allan Jensen from the Danish Cancer Society, Copenhagen, told Reuters Health.

Jensen and his associates evaluated the effects of different types of fertility drugs on the risk of breast cancer, after taking account of reproductive factors that are known to affect the risk, in a study involving more than 54,000 women with infertility problems.

Out of that whole group, 331 women developed breast cancer after an average of 14 years, the investigators report in the journal Cancer Epidemiology, Biomarkers, and Prevention.

After adjustment, the researchers found that clomiphene and four synthetic hormones used to boost fertility did not significantly affect the risk of breast cancer.

The use of progesterone was associated with an increased risk of subsequent breast cancer, the investigators say, but this increased risk was based on only eight cases.

“The progesterone results are limited by a low number of cases,” Jensen said. “We will therefore increase the follow-up period in order to collect more cases. Also, as progesterone is mainly used for IVF patients, we will go into more details with this subgroup.”

In any case, he added, “we are talking about small increased relative risks, and therefore the absolute risk will still be low.”

SOURCE: Cancer Epidemiology, Biomarkers, and Prevention, July 2007. 

RELATED STORIES:
Exercise helps breast cancer patients avoid anemia   Lonely rats more prone to breast cancer   Radiation treatment transforms breast cancer cells into cancer stem cells   Gauging genetic breast cancer risk reassures women   Study identifies 1 of the mechanisms behind breast cancer metastasis   HER-2 Status Predicts Success of Chemotherapy in Breast Cancer Treatment   Emotional Health Affects Exercise Patterns in Breast Cancer Patients   FDA Broadens Clearance For Agendia’s MammaPrint(R)   New Study Calls for Change In Deciding Frequency of Mammograms   Benefit of novel drug in breast cancer seen in blood within weeks   Regular use of COX-2 inhibitors reduces breast cancer risk   Drug combo ups breast cancer survival-study   Treatment delays result in poor outcomes for men with breast cancer   Researchers Develop New and Efficient Breast Biopsy Technique   Chemo drugs for treating breast cancer may cause changes in cognitive function   Study Assesses Neuropathic Pain Risk for Breast Cancer Patients   Concerns raised about surgeons performing occasional breast cancer operations   Dana-Farber study finds new points of attack on breast cancers not fueled by estrogen   Daily stress may stop breast cancer   Breast cancer incidence in Spain drops in early 2000s after decades of increasing rates   Why Do Some Women Develop Breast Cancer Earlier Than Others?   Partial Breast Radiation Focus of New Cancer Study

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]